NMPA Approval

Erythromycin Estolate Granules

Approval Number

国药准字H34022668

Company吉林万通药业集团梅河药业股份有限公司

Registration Date

August 17, 2020

Previous Approval Numbers

国药准字H34022668

Drug Information

Generic Name

依托红霉素颗粒

Dosage Form

颗粒剂

Strength

按C₃₇H₆₇NO₁₃计算75mg（7.5万单位）

Drug Type

化学药品

Registration Date

August 17, 2020

Company Information

Applicant Company

Company Name吉林万通药业集团梅河药业股份有限公司

Company Address

吉林省梅河口市万通路666号

Manufacturing Company

Company Name合肥利民制药有限公司

Company Address

安徽省合肥市肥西县桃花镇玉兰大道41号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

依托红霉素颗粒 - NMPA 批准文号 | MedPath